Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome

Moghetti, Paolo, Tosi, Flavia, Bonin, Cecilia, Di Sarra, Daniela, Fiers, Tom, Kaufman, Jean-Marc, Giagulli, Vito Angelo, Signori, Chiara +5 more·2013·The Journal of Clinical Endocrinology & Metabolism
DOI 10.1210/jc.2012-3908

Cited by (262)

Items 101–200 of 262

  1. Association of insulin resistance with polycystic ovary syndrome phenotypes and patients’ characteristics: a cross-sectional study in Iran
    Leili Rahmatnezhad, Lida Moghaddam‐Banaem, Tahereh Behroozi-Lak, Afshin Shiva, Javad Rasouli · 2023 · Reproductive Biology and Endocrinology
  2. Treatment with d -chiro-inositol and alpha lipoic acid in the management of polycystic ovary syndrome
    Franca Fruzzetti, Anna Capozzi, Alessio Canu, Stefano Lello · 2019 · Gynecological Endocrinology
  3. Polycystic ovary morphology is associated with insulin resistance in women with polycystic ovary syndrome
    So‐hyeon Hong, Yeon‐Ah Sung, Young Sun Hong, Kyungah Jeong, Hyewon Chung, Hyejin Lee · 2017 · Clinical Endocrinology
  4. Hemostatic and Fibrinolytic Abnormalities in Polycystic Ovary Syndrome
    Giacomo Zoppini, Enzo Bonora, Paolo Moghetti, Giovanni Targher · 2014 · Seminars in Thrombosis and Hemostasis
  5. Is cardiorespiratory fitness impaired in PCOS women? A review of the literature
    Donà, S., Bacchi, E., Moghetti, P. · 2017 · Journal of Endocrinological Investigation
  6. Comparison of selected exercise training modalities in the management of PCOS: A systematic review and meta-analysis to inform evidence-based guidelines
    Giorgia Elisabeth Colombo, Xela Dafauce Bouzo, Rhiannon Kate Patten, Aya Mousa, Chau Thien Tay, Loyal Pattuwage, Helena Jane Teede, Leanne Maree Redman, Angelica Lindén Hirschberg, Angelo Sabag · 2023 · JSAMS Plus
  7. Association between The Number of Retrieved Mature Oocytes and Insulin Resistance or Sensitivity in Infertile Women with Polycystic Ovary Syndrome.
    Fatemeh Hassani, Shahrbanoo Oryan, Poopak Eftekhari‐Yazdi, Masood Bazrgar, Ashraf Moini, Nahid Nasiri, Azadeh Ghaheri · 2019 · Europe PMC (PubMed Central)
  8. Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary Syndrome
    Krystallenia Alexandraki, Eleitho Practice, Athens, Greece, Eleni Kandaraki, Kalliopi‐Anna Poulia, Christina Piperi, Eirini Papadimitriou, Theo Papaioannou · 2021 · touchREVIEWS in Endocrinology
  9. Menstrual dysfunction—a proxy for insulin resistance in PCOS?
    Héctor Francisco Escobar-Morreale · 2013 · Nature Reviews Endocrinology
  10. How to manage the reproductive issues of PCOS: a 2015 integrated endocrinological and gynecological consensus statement of the Italian Society of Endocrinology
    Paolo Moghetti, Enrico Carmina, Vincenzo De Leo, Antonio Lanzone, Francesco Orio, Riccardo Pasquali, Vincenzo Toscano · 2015 · Journal of Endocrinological Investigation
  11. Current treatment for polycystic ovary syndrome: focus on adolescence
    Maria Elisabeth Street, Francesca Cirillo, Cecilia Catellani, Marco Dauriz, Pietro Lazzeroni, Chiara Sartori, Paolo Moghetti · 2020 · Minerva Pediatrics
  12. Targets to treat androgen excess in polycystic ovary syndrome
    Manuel Luque‐Ramírez, Héctor Francisco Escobar-Morreale · 2015 · Expert Opinion on Therapeutic Targets
  13. Metabolic Syndrome Rather Than Other Phenotypes in PCOS as a Predictive Indicator for Clinical Outcomes in IVF: Comprehensive Phenotypic Assessment across All PCOS Classifications
    Manfei Si, Wanxue Xu, Xinyu Qi, Huahua Jiang, Yue Zhao, Rong Li, Xiaoyu Long, Jie Qiao · 2023 · Journal of Clinical Medicine
  14. Gut Metabolites Are More Predictive of Disease and Cohoused States than Gut Bacterial Features in a Polycystic Ovary Syndrome-Like Mouse Model
    Bryan Ho, Daniel Ryback, Basilin Benson, Cayla N. Mason, Pedro J. Torres, Robert A. Quinn, Varykina G. Thackray, Scott Theodore Kelley · 2021 · mSystems
  15. POLYCYSTIC OVARY SYNDROME: ORIGINS AND IMPLICATIONS: Polycystic ovary syndrome: the impact of androgen excess on metabolic health
    Leanne Cussen, Tara McDonnell, Clare Miller, Marie McIlroy, Michael O’Reilly · 2025 · Reproduction
  16. Key signalling pathways underlying the aetiology of polycystic ovary syndrome
    Kirsty A. Walters, Alba Moreno-Asso, Nigel K. Stepto, Michaël W. Pankhurst, Valentina Rodriguez Paris, Raymond Joseph Rodgers · 2022 · Journal of Endocrinology
  17. Risk factors for insulin resistance related to polycystic ovarian syndrome in Iranian population
    Asieh Mansour, Maryam Mirahmad, Mohammad Reza Mohajeri‐Tehrani, Mahdieh Jamalizadeh, Sedigheh Hosseinimousa, Fatemeh Rashidi, Pooria Asili, Sayed Mahmoud Sajjadi‐Jazi · 2023 · Scientific Reports
  18. Correlation between anti-mullerian hormone with insulin resistance in polycystic ovarian syndrome: a systematic review and meta-analysis
    Mohd Zakwan Md Muslim, Aniza Mohammed Jelani, Noorazliyana Shafii, Najib Majdi Yaacob, Noor Azlin Azraini Che Soh, Hanim Afzan Ibrahim · 2024 · Journal of Ovarian Research
  19. Improvement of endocrine and metabolic conditions in patients with polycystic ovary syndrome through acupuncture and its combined therapies: a systematic review and meta-analysis
    Tianyu Wu, Yiwei Liu, Fanjing Kong, Jinqun Hu, Yu Liu, Jie Yang, Jiao Chen · 2025 · Annals of Medicine
  20. The PNA mouse may be the best animal model of polycystic ovary syndrome
    Jingyi Ren, Guangqing Tan, Xinyi Ren, Weiyu Lu, Qiling Peng, Jing Ping Tang, Yingxiong Wang, Biao Xie, Meijiao Wang · 2022 · Frontiers in Endocrinology
  21. Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome
    Barber, Thomas M, Franks, Stephen · 2013 · Expert Review of Endocrinology & Metabolism
  22. Polycystic Ovary Syndrome and the Potential for Nanomaterial-Based Drug Delivery in Therapy of This Disease
    Mingqin Shi, Xinyao Li, Liwei Xing, Zhenmin Li, Sitong Zhou, Zihui Wang, Xuelian Zou, Yuqing She, Rong Zhao, Dongdong Qin · 2024 · Pharmaceutics
  23. Adipose Tissue is a Potential Source of Hyperandrogenism in Obese Female Rats
    Isabel Viola Wagner, Lena Sahlin, Iuliia Savchuk, Nora Klöting, Konstantin Svechnikov, Olle Söder · 2018 · Obesity
  24. Non-cell autonomous mechanisms control mitochondrial gene dysregulation in polycystic ovary syndrome
    Alba Moreno‐Asso, Ali Altıntaş, Luke C. McIlvenna, Rhiannon Kate Patten, Javier Botella, Andrew J McAinch, Raymond J Rodgers, Romain Barrès, Nigel K. Stepto · 2021 · Journal of Molecular Endocrinology
  25. Polycystic Ovary Syndrome and Obesity
    Thomas M. Barber, Georgios K. Dimitriadis, Stephen Franks · 2015 · Springer eBooks
  26. Enhancing understanding of endometrial function in patients with PCOS: clinical and immunological insights
    Yaxin Guo, Jingfei Yang, Hong Chen, Yueping Zhou, Yan Yang, Biao Wang, Luyang Zha, Dijia Bai, Wenxuan Li, Xiaojuan Tang et al. · 2025 · Journal of Ovarian Research
  27. Angiotensin Converting Enzyme (ACE) Gene I/D Polymorphism Is Significantly Associated with Insulin Resistance and Polycystic Ovary Syndrome: A Meta-Analysis
    Jie Li, Zhong Lin, Shujia Wang, Qiuling Shi · 2023 · Gynecologic and Obstetric Investigation
  28. Are Patients with Polycystic Ovarian Syndrome Ideal Candidates for Oocyte Donation?
    George Queiroz Vaz, Alessandra Viviane Evangelista, Cassio Alessandro Paganoti Sartorio, Maria Cecilia Almeida Cardoso, Maria Cecília Erthal, Paulo Gallo, Marco Aurélio Pinho Oliveira · 2016 · BioMed Research International
  29. Treatment with Myo-Inositol Does Not Improve the Clinical Features in All PCOS Phenotypes
    Vittorio Unfer, Michele Russo, Cesare Aragona, Gabriele Bilotta, Mario Montanino Oliva, Mariano Bizzarri · 2023 · Biomedicines
  30. Genotype based Risk Predictors for Polycystic Ovary Syndrome in Western Saudi Arabia
    Sherin Bakhashab · 2019 · Bioinformation
  31. Hyperandrogenism, Insulin Resistance, and Acanthosis Nigricans (HAIR-AN) Syndrome Reflects Adipose Tissue Dysfunction (“Adiposopathy” or “Sick Fat”) in Asian Indian Girls
    Kritika Agrawal, Rachita Mathur, Naincy Purwar, S. Mathur, D. Mathur · 2021 · Dermatology
  32. The Role of Androgen Excess in Metabolic Dysfunction in Women
    Héctor Francisco Escobar-Morreale · 2017 · Advances in experimental medicine and biology
  33. Deciphering the interplay between oxidative stress and inflammation in polycystic ovary syndrome: outcome of a case-control study
    Khurshid Ahmad Padder, Nusrat Jahan, Muhammad Yousuf, Idrees Ayoub Shah, Gulzar Ahmad Bhat, Rabia Khurshid, Mahrukh Hameed Zargar, Mohd Ashraf Ganie · 2025 · Journal of Ovarian Research
  34. Women with PCOS have a heightened risk of cardiometabolic and cardiovascular diseases: statement from the Experts Group on Inositol in Basic and Clinical Research and PCOS (EGOI-PCOS) and Italian Association of Hospital Cardiologists (ANMCO)
    Giovanna Geraci, Carmine Riccio, Fabrizio Giovanni Oliva, Domenico Gabrielli, Furio Colivicchi, Massimo Grimaldi, Fabio Facchinetti, Vittorio Unfer · 2025 · Frontiers in Cardiovascular Medicine
  35. Characterizing skeletal muscle dysfunction in women with polycystic ovary syndrome
    Tara McDonnell, Leanne Cussen, Marie McIlroy, Michael O’Reilly · 2022 · Therapeutic Advances in Endocrinology and Metabolism
  36. Endocrine characteristics, body mass index and metabolic syndrome in women with polycystic ovary syndrome
    Jian Li, Qi Wu, Chi Chiu Wang, Rui Wang, Ernest Hung Yu Ng, Jianping Liu, Ben W. Mol, Xiao-Ke Wu, Wentao Li · 2019 · Reproductive BioMedicine Online
  37. Exaggerated glucagon responses to hypoglycemia in women with polycystic ovary syndrome
    Susan Sam, Priyathama Vellanki, Sudha K. Yalamanchi, Richard N. Bergman, Andrea Elizabeth Dunaif · 2017 · Metabolism
  38. Polycystic ovary syndrome
    Hatice Lamia Aydın, Batuhan Sarp Dayan, Nur DOKUZEYLÜL GÜNGÖR · 2023 · Journal of Controversies in Obstetrics & Gynecology and Pediatrics
  39. Hyperandrogenemia is Common in Asymptomatic Women and is Associated with Increased Metabolic Risk
    Laura Christine Torchen, Joy N. Tsai, Prathima Jasti, Rodrigo Macaya, Ryan K. Sisk, Matthew Dapas, M. Geoffrey Hayes, Margrit Urbanek, Andrea Elizabeth Dunaif · 2019 · Obesity
  40. Diet and Exercise in the Management of Polycystic Ovary Syndrome: Practical Considerations for Person-Centered Care
    Giorgia Elisabeth Colombo, Stephanie Pirotta, Angelo Sabag · 2023 · Seminars in Reproductive Medicine
  41. Serum zonulin level is not elevated in patients with polycystic ovary syndrome without metabolic syndrome
    Zeynep Çetin, Arzu Kösem, Bülent Canbaz, Özden Özdemir Başer, Merve Çatak, Turan Turhan, Dilek Sensoz Berker · 2019 · Archives of Gynecology and Obstetrics
  42. Vitamin B3 (niacin), B6, C, and iron intake are associated with the free androgen index, especially in normoandrogenic polycystic ovary syndrome
    Andon Brilliant, Brilliant Putri Kusuma Astuti, Ericko Ongko Joyo, Ririn Rahmala Febri, Vita Silvana, Raden Muharam · 2022 · Journal of the Turkish-German Gynecological Association
  43. Prenatal undernutrition affects the phenotypes of PCOS model rats
    Takeshi Iwasa, Toshiya Matsuzaki, Kiyohito Yano, Yiliyasi Mayila, Rie Yanagihara, Yuri Yamamoto, Akira Kuwahara, Minoru Irahara · 2018 · Journal of Endocrinology
  44. Serum testosterone predicts cardiorespiratory fitness impairment in normal‐weight women with polycystic ovary syndrome
    Bacchi, Elisabetta, Negri, Carlo, Di Sarra, Daniela, Tosi, Flavia, Tarperi, Cantor, Moretta, Rossella, Schena, Federico, Bonora, Enzo, Kaufman, Jean‐Marc, Moghetti, Paolo · 2015 · Clinical Endocrinology
  45. The Role of Sodium-Glucose Cotransporter-2 Inhibitors in the Treatment of Polycystic Ovary Syndrome: A Review
    Rachel Porth, Karina Oelerich, Mala S. Sivanandy · 2024 · Journal of Clinical Medicine
  46. Levels of circulating insulin cell-free DNA in women with polycystic ovary syndrome – a longitudinal cohort study
    Pernille Bækgaard Udesen, Anja E. Sørensen, Mugdha V. Joglekar, Anandwardhan A. Hardikar, Marie Louise Wissing, Anne Lis Mikkelsen Englund, Louise T. Dalgaard · 2019 · Reproductive Biology and Endocrinology
  47. Using metabolic markers to identify insulin resistance in premenopausal women with and without polycystic ovary syndrome
    Manuel R. Blum, Rita A. Popat, Alexandra Nagy, Nicholas A. Cataldo, Tracey McLaughlin · 2021 · Journal of Endocrinological Investigation
  48. Predictive factors of polycystic ovary syndrome in girls with precocious pubarche
    Valentina Guarnotta, Silvia Lucchese, Mariagrazia Irene Mineo, Donatella Mangione, Renato Venezia, Piero Luigi Almasio, Carla Santos de Souza Giordano · 2021 · Endocrine Connections
  49. Síndrome de ovario poliquístico. diagnóstico y manejo
    P. Teresa Sir, R. Jessica Preisler, N. Amiram Magendzo · 2013 · Revista Médica Clínica Las Condes
  50. Certified testosterone immunoassays for hyperandrogenaemia
    Manuel Luque‐Ramírez, Lucía Jiménez Mendiguchía, Ana María García Cano, Elena Fernández‐Durán, Verónica de Dios Rosa, Lía Nattero‐Chávez, A.E. Ortiz-Flores, Héctor Francisco Escobar-Morreale · 2018 · European Journal of Clinical Investigation
  51. Diagnosis and Treatment of Adolescent Polycystic Ovary syndrome:A Review
    Yaoyang Zhang, Kaiyu Yang, Ting Fan, Dongying Zheng, Hongxiu Liu · 2025 · International Journal of Women s Health
  52. Serum HMGB1 levels are independently associated with glucose clamp-derived measures of insulin resistance in women with PCOS
    Paolo Moghetti, Cecilia Catellani, Chiara Sartori, Matteo Migazzi, F. Cirillo, M. Villani, V Buia, Beatrice Righi, Marco Dauriz, Tom Fiers et al. · 2023 · Journal of Endocrinological Investigation
  53. Metabolic disparities between obese and non-obese patients with polycystic ovary syndrome: implications for endometrial receptivity indicators
    Xiaoli Li, Yan-fei Ji, Yu Feng, Shiwei Liu · 2024 · Gynecological Endocrinology
  54. Influence of state-of-the-art laboratory techniques on the phenotyping of women with polycystic ovary syndrome in the clinical setting
    Manuel Luque‐Ramírez, María Ángeles Martínez-García, María Rosa Insenser, Elena Fernández‐Durán, Alejandra Quintero-Tobar, Tom Fiers, J.-M. Kaufman, Ana María García Cano, M. Rosillo Coronado, Lía Nattero‐Chávez et al. · 2024 · Journal of Endocrinological Investigation
  55. Disorders of the glucose metabolism correlate with the phenotype and the severity in women with polycystic ovary syndrome
    Josef van Helden, Osman Evliyaoğlu, Andreas Küberl, Ralf Weiskirchen · 2020 · Clinical Endocrinology
  56. Defining PCOS: A syndrome with an intrinsic heterogeneous nature
    Héctor Francisco Escobar-Morreale · 2021 · Elsevier eBooks
  57. Obesity and Hyperandrogenemia in Polycystic Ovary Syndrome: Clinical Implications
    Mardia López‐Alarcón, Víctor Saúl Vital-Reyes, Eduardo Almeida‐Gutiérrez, Jorge Maldonado‐Hernández, Salvador Flores, Juan Manuel Domínguez-Salgado, José Vite-Bautista, David Cruz-Martínez, Aly Sugei Barradas-Vázquez, Ricardo Z’Cruz-López · 2023 · Journal of Personalized Medicine
  58. Delphi consensus on the diagnostic criteria of polycystic ovary syndrome
    Fabio Facchinetti, Alessandra Gambineri, Gianluca Aimaretti, Alberto Ferlin, Antonio Simone Laganà, Paolo Moghetti, Mario Montanino Oliva, Vittorio Unfer, Annamaria Anita Livia Colao · 2025 · Journal of Endocrinological Investigation
  59. Das polyzystische Ovarsyndrom als genderspezifischer kardiometabolischer Risikofaktor
    Lukas van Baal, Susanne Tan · 2023 · Die Innere Medizin
  60. Clinical Impact of Insulin Resistance in Women with Polycystic Ovary Syndrome
    Maria Mitkova Orbetzova · 2020 · IntechOpen eBooks
  61. Can dysglycemia in OGTT be predicted by baseline parameters in patients with PCOS?
    Sarantis Livadas, Christina Bothou, Justyna Kuliczkowska-Płaksej, Ralitsa Robeva, Andromahi Vryonidou, Jelica Bjekic Macut, Ioannis Androulakis, Milica Opalic, Zadalla Mouslech, Andrej Milewicz et al. · 2022 · Endocrine Connections
  62. Polycystic Ovary Syndrome: Not Just a Fertility Problem
    Stephen Franks · 2015 · Women s Health
  63. Alterations of insulin sensitivity, clearance, and secretion, either alone or in combination, in women with PCOS: impact on metabolic profile and androgenemia
    Flavia Tosi, Maria Giovanna Lando, Federica Rosmini, Federico Lucarini, Veronica Fiorio, Maria Elisabetta Zanolin, Tom Fiers, Jean‐Marc Kaufman, Paolo Moghetti · 2025 · Human Reproduction
  64. Insulin resistance: still an underestimated factor in polycystic ovary syndrome?
    Anna Lena Zippl, Beata Seeber, L. Wildt · 2021 · Fertility and Sterility
  65. Combined Oral Contraceptives for Polycystic Ovary Syndrome: Pro and Contra (Review)
    И. А. Мазеркина, I. G. Davydov, Аляутдина Ольга Сергеевна · 2024 · Safety and Risk of Pharmacotherapy
  66. The role of berberine in polycystic ovary syndrome — a summary of knowledge
    Jan Jurgiel, Adrianna Graniak, Piotr Opyd, Tomasz Zawodny, Michał Lis · 2023 · Ginekologia Polska
  67. Diabetes advice for women with polycystic ovary syndrome: prevention, prevention, prevention
    Hamidreza Mani, Kamlesh K. Khunti, Miles J Levy, Melanie Jane Davies · 2013 · Diabetes Management
  68. Prevalence, phenotypic distribution, and clinical characteristics of polycystic ovary syndrome in Egyptian women with type 1 diabetes mellitus
    AyatI Ghanem, DinaH Abd Elmonem, FatmaK Hammad, EmanM Aly · 2022 · Journal of Medicine in Scientific Research
  69. Metabolic implications of menstrual cycle length in non-hyperandrogenic women with polycystic ovarian morphology
    Miro Šimun Alebić, Nataša Stojanović, Dinka Pavičić Baldani, Lea Smircic Duvnjak · 2016 · Endocrine
  70. Longitudinal trajectories of insulin resistance in women with polycystic ovary syndrome: a functional data analysis approach
    Fahimeh Ramezani Tehrani, Mohammad Fayaz, Faegheh Firouzi, Fereidoun Azizi, Maryam Tohidi, Samira Behboudi‐Gandevani · 2025 · Endocrine Connections
  71. Linking altered gut microbiome to polycystic ovarian syndrome through immune mediated pathway
    Vaishnavi A. Pathak, Sanjay Jayprakash Kshirsagar, Gitanjali Sambhajirao Deokar · 2025 · Journal of Reproductive Immunology
  72. Prevalence and Predictors of Impaired Glucose Tolerance and Diabetes Mellitus Type 2 in Patients with Polycystic Ovary Syndrome
    Brankica Krstevska, Sasha Jovanovska Mishevska, Valentina Velkoska Nakova, Vladimir Serafimoski · 2021 · PRILOZI
  73. [Proinflammatory cytokines in polycystic ovarian syndrome].
    Manuel Ramón García-Sáenz, Aldo Ferreira‐Hermosillo, Miry Lobaton-Ginsberg · 2022 · PubMed Central
  74. Metabolic Syndrome in Polycystic Ovary Syndrome
    Yun-Chiao Hsieh, Po-Kai Yang, Mei‐Jou Chen · 2021 · Fertility & Reproduction
  75. Características clínicas, hormonales, bioquímicas y prevalencia del Síndrome de Ovario Poliquístico en mujeres del Eje Cafetero, Colombia, 2016-2020
    Franklin José Espitia De La Hoz · 2022 · Revista Colombiana de Endocrinología Diabetes & Metabolismo
  76. [New populations at increased cardiovascular risk: Cardiovascular disease in dermatological diseases].
    E. Godoy-Gijon, C. Meseguer-Yebra, L. Palacio-Aller, D. Godoy-Rocati, C. Lahoz-Rallo · 2016 · Clínica e Investigación en Arteriosclerosis
  77. Pathophysiology of Ovarian Function in the Human Female
    Stephen Franks, Kate Hardy, Gerard S. Conway · 2014 · Elsevier eBooks
  78. Polycystic ovary syndrome (PCOS) – role of chronic inflammation in the expression of dysmetabolic phenotype
    Elena Popa, Ana-Aurelia Chiş-Şerban, Adorata Elena Coman · 2023 · Medic ro
  79. Visible signs of insulin resistance: opportunities lost
    G Nagamani, P. G. Sundararaman, Gumpeny Ramachandra Sridhar · 2014 · International Journal of Diabetes in Developing Countries
  80. Clasificación de los fenotipos de síndrome de ovario poliquístico de acuerdo a los criterios de Rotterdam: ¿una condición estática o variable?
    Bárbara Echiburú, Amanda Ladrón de Guevara, Cecilia Pereira, Constanza Pérez, Pía Michael · 2014 · Revista médica de Chile
  81. Clinical profile of PCOS patients in a rural tertiary care hospital
    Sushma P. Sharma, Jankidevi S. Borade · 2019 · International Journal of Clinical Obstetrics and Gynaecology
  82. Das polyzystische Ovar-Syndrom – Entstehung, Behandlung und neue Erkenntnisse
    Valentin Borzan, Anna Mayr, Barbara Maria Obermayer-Pietsch · 2021 · Journal für Klinische Endokrinologie und Stoffwechsel
  83. Metabolic dysfunction correction as a method of restoring the function of the reproductive system in women
    Чернуха Галина Евгеньевна, Пронина Вероника Алексеевна · 2023 · Meditsinskiy sovet = Medical Council
  84. Primary and secondary prevention of metabolic and cardiovascular comorbidities in women with polycystic ovary syndrome.
    P. Spritzer · 2015 · Revista Brasileira de Ginecologia e Obstetrícia
  85. Pathophysiology of PCOS
    Priyadarshini Sahu, Nidhi Sharma, Amalia Tsiatoura · 2024 · Springer eBooks
  86. Research progress on insulin resistance in polycystic ovary syndrome
    Yang-Bin Qi, Peng Yi, Xudong Fu · 2025 · Reproductive and Developmental Medicine
  87. Cardiometabolic risk in women with polycystic ovary syndrome: a comprehensive review
    Angelo Cagnacci, Gino A. ANTONELLI, Giulia VATTERONI, Anjeza Xholli · 2025 · Minerva Obstetrics and Gynecology
  88. The Combination of Diosgenin, Vitamin D, and α-Lactalbumin Normalizes the Menstrual Cycle in Women with PCOS of Phenotype D: A Pilot Clinical Study
    Michele Russo, Giuseppina Porcaro, Cesare Aragona, Gabriele Bilotta, Massimo Di Liberto, Vittorio Unfer · 2025 · Nutrients
  89. Non-contraceptive Benefits of Hormonal Methods
    Renato Seracchioli, Simona Del Forno, Eugenia Degli Esposti · 2021 · Trends in andrology and sexual medicine
  90. Polycystic ovary syndrome and metabolic syndrome: Risks in later life
    Aisha Sheikh · 2023 · Elsevier eBooks
  91. Peroxisome proliferator-activated receptors and placental function in women with polycystic ovary syndrome
    Aimé Florencia Silva, Alicia Beatriz Motta · 2024 · Reproduction
  92. Multiomics in polycystic ovarian syndrome
    Farhat Jabeen, Rais Ahmad, Seerat Rasool, Aarif Ali, Showkat Ahmad Ganie · 2024 · Elsevier eBooks
  93. Global, regional, and national burden of polycystic ovary syndrome, 1990–2021: a comprehensive analysis of trends and projections based on the global burden of disease 2021 study
    Bingxue Ning, Mengjie Zhang, Nan Su, Raowan Bur, Haozhe Ma, Kun Liu, Xiaolin La · 2025 · Gynecological Endocrinology
  94. Serum Uric Acid Concentration in Overweight and Obese Women with Polycystic Ovary Syndrome / Nivelul acidului uric la femeile supraponderale și obeze cu sindromul ovarelor polichistice
    Letiția Leuștean, Cristina Dimitriu, Simona Vasilica Fica, Maria-Christina Ungureanu, Cristina Preda, Voichiţa Mogoş, Didona Anca Ungureanu, Carmen Vulpoi · 2015 · Revista română de medicină de laborator
  95. Синдромом поликистозных яичников и их взаимосвязь с микробиотой кишечника и влагалища (Обзор литературы)
    Анастасия Сергеевна Толстова, Максим Владимирович Морозов, Олег Васильевич Родин, Никита Александрович Фазилов, Андрей Александрович Кох, Ангелина Александровна Безжонова · 2021 · Естественные и Технические Науки
  96. The multifarious role of insulin in PCOS: From pathophysiology to therapeutic management
    Paolo Moghetti · 2021 · Elsevier eBooks
  97. Obez ve Obez Olmayan Polikistik Over Sendromlu Adolesanların Klinik ve Laboratuvar Özelliklerinin Karşılaştırılması
    Aynur Bedel, Hale Tuhan, Eren İsmailoğlu, Deniz Özalp Kızılay, Sezer Acar · 2021 · Akdeniz Medical Journal
  98. Metabolic and lipoprotein aspects of polycystic ovarian syndrome
    Agnieszka Pazderska, James Gibney · 2015 · Clinical Lipidology
  99. Comparison of clinical and biochemical parameters in the ovulatory and anovulatory phenotypes of polycystic ovary syndrome
    Asena AYAR MADENLİ, Gönül Özer · 2023 · Journal of Controversies in Obstetrics & Gynecology and Pediatrics
  100. Research hotspots of polycystic ovary syndrome and hyperandrogenism from 2008 to 2022: bibliometric analysis
    Haijuan Liu, Xiaoting Fang, Qianru Ma, Mina Wang, Xiufang Hao, Guohua Wang · 2024 · Gynecological Endocrinology